|
|||||||
 |
A recent study has determined that rheumatoid arthritis (RA) patients that have prolonged use of drugs such as methotrexate, glucocorticoids and TNF-alpha blockers to control the disease may be protecting their hearts as well. Researchers from the University of Las Palmas de Gran Canaria in Spain studied data from over 4300 RA patients from 15 countries. One [...] People with Rheumatoid Arthritis (RA) have depressed immune systems and are therefore encouraged to get the annual flu vaccination. However, a recent study has found that RA patients who have taken rituximab may not get the same protection against the seasonal flu. Rituximab depletes B cells, which are responsible for producing antibodies against infections. Dutch researchers conducted [...] There are several treatments utilized for reducing joint inflammation and preventing or reducing joint damage due to rheumatoid arthritis (RA). Among the treatments are immunosuppressant drugs, which work by suppressing the response of the body’s immune system. Since the development of RA is related to anomalies with the immune system, controlling immune system response can [...] Biogen Idec Inc. announced on October 9th that it was discontinuing development of its investigational rheumatoid arthritis (RA) drug baminercept after if failed to meet Phase II study [...] Rheumatoid arthritis (RA) patients have been treated with several different drugs, including Enbrel (etanercept) and methotrexate. Now a study conducted in the United Kingdom indicates that treatment with a combination of Enbrel (an anti-TNF), and methotrexate increases the remission rate. Nearly 550 RA patients from Europe, Asia, Australia and Latin America, none of whom had used [...] |
  
|
|||||
|
Copyright © 2010 Current Arthritis News and Research - All Rights Reserved
|
|||||||
Recent Comments